de Thé H - Search Results

1

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.

Bertheau P, Turpin E, Rickman DS, Espié M, de Reyniès A, Feugeas JP, Plassa LF, Soliman H, Varna M, de Roquancourt A, Lehmann-Che J, Beuzard Y, Marty M, Misset JL, Janin A, de Thé H. Bertheau P, et al. Among authors: de the h, de reynies a, de roquancourt a. PLoS Med. 2007 Mar;4(3):e90. doi: 10.1371/journal.pmed.0040090. PLoS Med. 2007. PMID: 17388661 Free PMC article.

2

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia.

Lallemand-Breitenbach V, Guillemin MC, Janin A, Daniel MT, Degos L, Kogan SC, Bishop JM, de Thé H. Lallemand-Breitenbach V, et al. Among authors: de the h. J Exp Med. 1999 Apr 5;189(7):1043-52. doi: 10.1084/jem.189.7.1043. J Exp Med. 1999. PMID: 10190895 Free PMC article.

3

[Tissue microdissection: application to the study of cancer of the breast].

Bertheau P, de Thé H, de Roquancourt A, Lerebours F, Espié M, Janin A. Bertheau P, et al. Among authors: de the h, de roquancourt a. Ann Pathol. 1999;19(5 Suppl):S3-6. Ann Pathol. 1999. PMID: 10599450 French. No abstract available.

4

Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers.

Turpin E, Dalle B, de Roquancourt A, Plassa LF, Marty M, Janin A, Beuzard Y, de Thé H. Turpin E, et al. Among authors: de the h, de roquancourt a. Oncogene. 1999 Dec 16;18(54):7834-7. doi: 10.1038/sj.onc.1203196. Oncogene. 1999. PMID: 10618725

5

Microdissection and breast cancer.

Bertheau P, Rivet J, de Roquancourt A, de Thé H, Espié M, Janin A. Bertheau P, et al. Among authors: de the h, de roquancourt a. J Mol Med (Berl). 2000;78(7):B31. J Mol Med (Berl). 2000. PMID: 11043391 No abstract available.

6

Allelic loss detection in inflammatory breast cancer: improvement with laser microdissection.

Bertheau P, Plassa LF, Lerebours F, de Roquancourt A, Turpin E, Lidereau R, de Thé H, Janin A. Bertheau P, et al. Among authors: de the h, de roquancourt a. Lab Invest. 2001 Oct;81(10):1397-402. doi: 10.1038/labinvest.3780353. Lab Invest. 2001. PMID: 11598152 Free article.

7

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy.

Bertheau P, Plassa F, Espié M, Turpin E, de Roquancourt A, Marty M, Lerebours F, Beuzard Y, Janin A, de Thé H. Bertheau P, et al. Among authors: de the h, de roquancourt a. Lancet. 2002 Sep 14;360(9336):852-4. doi: 10.1016/S0140-6736(02)09969-5. Lancet. 2002. PMID: 12243922

8

Evidence of chromosome regions and gene involvement in inflammatory breast cancer.

Lerebours F, Bertheau P, Bieche I, Driouch K, De The H, Hacene K, Espie M, Marty M, Lidereau R. Lerebours F, et al. Among authors: de the h. Int J Cancer. 2002 Dec 20;102(6):618-22. doi: 10.1002/ijc.10729. Int J Cancer. 2002. PMID: 12448004

9

Protease-dependent uncoating of a complex retrovirus.

Lehmann-Che J, Giron ML, Delelis O, Löchelt M, Bittoun P, Tobaly-Tapiero J, de Thé H, Saïb A. Lehmann-Che J, et al. Among authors: de the h. J Virol. 2005 Jul;79(14):9244-53. doi: 10.1128/JVI.79.14.9244-9253.2005. J Virol. 2005. PMID: 15994819 Free PMC article.

10

Characterization of endogenous human promyelocytic leukemia isoforms.

Condemine W, Takahashi Y, Zhu J, Puvion-Dutilleul F, Guegan S, Janin A, de Thé H. Condemine W, et al. Among authors: de the h. Cancer Res. 2006 Jun 15;66(12):6192-8. doi: 10.1158/0008-5472.CAN-05-3792. Cancer Res. 2006. PMID: 16778193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters